Innovation Pharmaceuticals Inc (IPIX)

[slcimmuno]

Commentary from that other Board


by ogewen • 53 minutes ago Flag
It's been a while since I posted. CTIX could be comparable to AAPL in it's infancy only time will tell. Their immediate pipeline is remarkable to say the least. Most fledgling biopharma companies have only one drug in its pipeline. CTIX has 3 and all of them are in disparate areas of treatment. Prurisol is the sleeper, but in of itself could be seen as a blockbuster. Psoriasis is a global affliction . The worldwide prevalence of psoriasis is around 2%, (That's 70 to 140 million people) but studies in developed countries have reported higher prevalence rates of on average about 4.6%. Ten percent go on to develop arthritis. Psoriasis is a noncommunicable disease that manifests as a chronic inflammatory skin disease. Being an autoimmune disease it has been linked to other conditions such as ulcerative colitis and many more. It's uniqueness in treating this affliction is that it portends to not only treat symptomatically, but it's application is curative and treated systemically. Studies in Europe which are further along than US show remarkable results. I traveled there recently and heard "off the record" that it is the real deal. We'll see. That alone could give CTIX a $75-100 pps in the immediate future. Ran out of room will cont. with part 2
Now if you throw in B and K into the mix which is getting all the attention and rightfully so since they both are life saving drugs the pps could easily be in the $300-500 range near term. I can't even count the number of times the antibiotics that were failsafe that I treated patients with that became obsolete and ineffective in the past few years. The mutation of bacteria is advancing exponentially and as a doctor treating eye diseases is beyond alarming. B is a defensin-mimetic that is not susceptible to traditional drug resistance. With B alone CTIX could be in the above pps category. K would explode the pps to even greater heights. I won't bore all the knowledgeable investors on this MB with the salient facts regarding K. I've gone on too long as it is and I apologize for the lack of brevity. I thought it was time for all of us to take a step back and realize how powerful the CTIX arsenal is at this early point of time. Once again please accept my apology for this long quazi- dissertation. I welcome intelligent discussion whether they be pro or con. As you probably surmise I am long and have been since CTIX has been in the $1 pps. GTLA. All the best. Ogewen Less